HomeCompareCIMEF vs JNJ

CIMEF vs JNJ: Dividend Comparison 2026

CIMEF yields 2.74% · JNJ yields 2.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 CIMEF wins by $102.7K in total portfolio value
10 years
CIMEF
CIMEF
● Live price
2.74%
Share price
$1.41
Annual div
$0.04
5Y div CAGR
46.4%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$133.0K
Annual income
$51,361.74
Full CIMEF calculator →
JNJ
Johnson & Johnson
● Live price
2.13%
Share price
$244.44
Annual div
$5.20
5Y div CAGR
28%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.3K
Annual income
$4,689.40
Full JNJ calculator →

Portfolio growth — CIMEF vs JNJ

📍 CIMEF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodCIMEFJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, CIMEF + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
CIMEF pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CIMEF
Annual income on $10K today (after 15% tax)
$232.70/yr
After 10yr DRIP, annual income (after tax)
$43,657.48/yr
JNJ
Annual income on $10K today (after 15% tax)
$180.82/yr
After 10yr DRIP, annual income (after tax)
$3,985.99/yr
At 15% tax rate, CIMEF beats the other by $39,671.49/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CIMEF + JNJ for your $10,000?

CIMEF: 50%JNJ: 50%
100% JNJ50/50100% CIMEF
Portfolio after 10yr
$81.6K
Annual income
$28,025.57/yr
Blended yield
34.34%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

CIMEF
No analyst data
Altman Z
3.2
Piotroski
6/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
-6.4% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CIMEF buys
0
JNJ buys
0
No recent congressional trades found for CIMEF or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricCIMEFJNJ
Forward yield2.74%2.13%
Annual dividend / share$0.04$5.20
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR46.4%28%
Portfolio after 10y$133.0K$30.3K
Annual income after 10y$51,361.74$4,689.40
Total dividends collected$104.1K$15.4K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: CIMEF vs JNJ ($10,000, DRIP)

YearCIMEF PortfolioCIMEF Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$11,101$400.78$10,592$272.30+$509.00CIMEF
2$12,487$608.72$11,289$357.73+$1.2KCIMEF
3$14,297$936.84$12,123$472.89+$2.2KCIMEF
4$16,766$1,467.71$13,141$629.86+$3.6KCIMEF
5$20,294$2,354.87$14,408$846.81+$5.9KCIMEF
6$25,615$3,900.08$16,021$1,151.60+$9.6KCIMEF
7$34,143$6,735.20$18,122$1,588.22+$16.0KCIMEF
8$48,817$12,283.38$20,930$2,228.20+$27.9KCIMEF
9$76,263$24,029.11$24,792$3,191.91+$51.5KCIMEF
10$132,963$51,361.74$30,274$4,689.40+$102.7KCIMEF

CIMEF vs JNJ: Complete Analysis 2026

CIMEFStock

CIMC Enric Holdings Limited provides transportation, storage, and processing equipment for the clean energy, chemicals, environmental, and liquid food industries worldwide. Its Clean Energy segment manufactures and operates equipment for the storage, transportation, processing, and distribution of compressed natural gas trailers, seamless pressure cylinders, liquefied natural gas trailers and storage tanks, liquefied petroleum gas tanks and trailers, natural gas refuelling station systems, and natural gas compressors; and offers engineering, procurement, and construction services for the natural gas industry, as well as internet of things intelligent operation and management platform under the Anjiehui brand. It offers its products under the Enric, Sanctum, Hongtu, CIMC Tank, Cryobest, Hashenleng, YPDI, CIMC SOE, and CIMC Hydrogen brands. The company's Chemical and Environmental segment offers tank containers for the storage and transportation of liquefied or gasified chemicals under the CIMC Tank and Tankmiles brands. Its Liquid Food segment engineers, manufactures, and sells stainless steel tanks for storage and processing liquid food, such as beer, fruit juice and milk; and provides EPC services for brewery and other liquid food industries under the Ziemann Holvrieka, Briggs of Burton, McMillan, and DME brands. The company also manufactures compressors and accessories, and pressure vessels; offers business solutions for gas equipment; researches and develops technology for natural gas equipment; cryogenic storage and transportation equipment design, manufacture, and technical services; collects, processes, and sells renewable resources; offers terminal and depot, and nonmetallic scrap processing services; and repairs and maintains pressure vessels. The company was incorporated in 2004 and is headquartered in Shenzhen, the People's Republic of China. CIMC Enric Holdings Limited is a subsidiary of China International Marine Containers (Hong Kong) Limited.

Full CIMEF Calculator →

JNJHealthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →
📬

Get this CIMEF vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CIMEF vs SCHDCIMEF vs JEPICIMEF vs OCIMEF vs KOCIMEF vs MAINCIMEF vs ABBVCIMEF vs MRKCIMEF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.